# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-296456
Filing Date
2018-10-10
Accepted
2018-10-10 09:05:36
Documents
10
Period of Report
2018-11-29
Effectiveness Date
2018-10-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d616630ddef14a.htm | DEF 14A | 787517
2 | GRAPHIC | g616630dsp001.jpg | GRAPHIC | 208526
3 | GRAPHIC | g616630dsp002.jpg | GRAPHIC | 321735
4 | GRAPHIC | g616630g1009075000781.jpg | GRAPHIC | 21190
5 | GRAPHIC | g616630g1009075001062.jpg | GRAPHIC | 17445
6 | GRAPHIC | g616630g1009075001296.jpg | GRAPHIC | 22536
7 | GRAPHIC | g616630g1009075001530.jpg | GRAPHIC | 14050
8 | GRAPHIC | g616630g30n56.jpg | GRAPHIC | 1930
9 | GRAPHIC | g616630g42x55.jpg | GRAPHIC | 27891
10 | GRAPHIC | g616630page28.jpg | GRAPHIC | 10155
| Complete submission text file | 0001193125-18-296456.txt |  | 1678666

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 181114967
SIC: 2835 In Vitro & In Vivo Diagnostic Substances